Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorMelphalanLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisCytarabineStem CellsHodgkin DiseaseGranulocytesDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesNeoplasmsTissue DonorsSurvival RateWhole-Body IrradiationInfectionSurvival AnalysisTime FactorsLymphoma, T-CellDoxorubicinPlatelet CountHistocompatibilityPOEMS SyndromePrednisoneCarboplatinHistocompatibility TestingImmunosuppressive AgentsLeukemia, Myeloid, AcuteDexamethasoneVidarabineTransplantation, IsogeneicRecombinant ProteinsFollow-Up StudiesBlood Cell CountLeukemiaAntineoplastic AgentsBone Marrow PurgingBlood CellsLymphomaProspective StudiesCytomegalovirus InfectionsFatal OutcomeGraft vs Leukemia EffectFeasibility StudiesMyelodysplastic SyndromesAnemia, AplasticImmunophenotypingBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationLymphocyte DepletionBone MarrowT-LymphocytesLeukocytes, MononuclearHematologic DiseasesOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellLivedo ReticularisPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensCyclosporinePrognosisBlood DonorsBreast NeoplasmsCell SeparationImmunosuppression